Key Market Indicators
Sales of beta-blocking medicines in Costa Rica are expected to reach $1.3 million by 2026. This figure was just $1.2 million in 2021, with a year-on-year average growth rate of 0.9%. Since 2012, sales have dropped by 5.4% annually. In 2021, Costa Rica was ranked 26th in the world. Iceland was the biggest market with $1.2 million, followed by Italy, Canada and Australia.
